ENTYVIO (vedolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** VEDOLIZUMAB

**Strength:** 108 mg/.68mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** BLA (BLA761133)

**Pharmacologic class:** Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]